title: Is a prospective trial necessary to suggest a clinical relevance?
authors.affiliation: Department of Neurosurgery, Sainte-Anne Hospital, Paris, France (J.P.); University Paris Descartes, PRES Sorbonne Paris Cité, France (J.P.); Réseau d'Etude des Gliomes, REG, Groland, France (J.P., H.D.); Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier, France (H.D.).
authors.forename: Johan
authors.initials: J
authors.lastname: Pallud
authors.affiliation: Department of Neurosurgery, Sainte-Anne Hospital, Paris, France (J.P.); University Paris Descartes, PRES Sorbonne Paris Cité, France (J.P.); Réseau d'Etude des Gliomes, REG, Groland, France (J.P., H.D.); Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier, France (H.D.).
authors.forename: Hugues
authors.initials: H
authors.lastname: Duffau
mesh_terms: D001932:Brain Neoplasms / Q000235:genetics* / Q000473:pathology*; D005260:Female; D005910:Glioma / Q000235:genetics* / Q000473:pathology*; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000235:genetics*; D008297:Male; D009154:Mutation / Q000235:genetics*
chemical_list: D007521:Isocitrate Dehydrogenase
references.citation: Neurology. 2010 May 25;74(21):1724-31
references.pmid: 20498440
references.citation: J Neurooncol. 2010 Mar;97(1):73-80
references.pmid: 19727562
references.citation: Ann Neurol. 2007 May;61(5):484-90
references.pmid: 17469128
references.citation: Neurosurg Rev. 2010 Jan;33(1):91-6
references.pmid: 19847462
references.citation: Neuro Oncol. 2010 Oct;12(10):1078-82
references.pmid: 20488959
references.citation: Neurosurgery. 2012 Sep;71(3):729-39; discussion 739-40
references.pmid: 22668885
references.citation: Neuro Oncol. 2013 May;15(5):595-606
references.pmid: 23393207
references.citation: Neuro Oncol. 2014 Aug;16(8):1100-9
references.pmid: 24847087
references.citation: Ann Neurol. 2006 Sep;60(3):380-3
references.pmid: 16983683
references.citation: J Neurooncol. 2012 May;108(1):69-75
references.pmid: 22392125